55 related articles for article (PubMed ID: 1886709)
21. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
22. Selective loss of H-2Ds antigen on a murine B lymphoma due to a post-transcriptional block in expression.
Luo H; Sopchak L; Lerman SP; King SR
Mol Immunol; 1995 Oct; 32(14-15):1011-20. PubMed ID: 8544850
[TBL] [Abstract][Full Text] [Related]
23. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
24. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
25. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
26. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
27. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
[TBL] [Abstract][Full Text] [Related]
28. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
29. Proto-oncogene expression in avian hematopoietic tissues.
Schuur ER; Baluda MA
Oncogene; 1991 Aug; 6(8):1409-15. PubMed ID: 1886713
[TBL] [Abstract][Full Text] [Related]
30. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
[TBL] [Abstract][Full Text] [Related]
31. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
32. Expression of oncogenes in normal and transformed murine B lymphocytes.
DeCino P; Lernhardt W; Herbst H; Raschke WC
Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of c-onc genes in choriocarcinoma cells].
Fujino T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
[TBL] [Abstract][Full Text] [Related]
34. Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
Mol Carcinog; 2002 Oct; 35(2):93-102. PubMed ID: 12325039
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
36. C-MYB activation and the pathogenesis of ovarian cancer.
Barletta C; Lazzaro D; Prosperi Porta R; Testa U; Grignani F; Ragusa RM; Leone R; Patella A; Carenza L; Peschle C
Eur J Gynaecol Oncol; 1992; 13(1):53-9. PubMed ID: 1547794
[TBL] [Abstract][Full Text] [Related]
37. Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.
Yokota J; Tsunetsugu-Yokota Y; Battifora H; Le Fevre C; Cline MJ
Science; 1986 Jan; 231(4735):261-5. PubMed ID: 3941898
[TBL] [Abstract][Full Text] [Related]
38. Alternative internal splicing in c-myb RNAs occurs commonly in normal and tumor cells.
Shen-Ong GL
EMBO J; 1987 Dec; 6(13):4035-9. PubMed ID: 2832149
[TBL] [Abstract][Full Text] [Related]
39. A CD34-negative
Wang HY; Thorson JA
Blood; 2017 Mar; 129(10):1403. PubMed ID: 28280048
[No Abstract] [Full Text] [Related]
40. Synergy of Myc, cell cycle regulators and the Akt pathway in the development of aggressive B-cell lymphoma in a mouse model.
Arita K; Tsuzuki S; Ohshima K; Sugiyama T; Seto M
Leukemia; 2014 Nov; 28(11):2270-2. PubMed ID: 25034145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
